Memorial Sloan Kettering Cancer Center
HR+ Breast Cancer: Individualizing Therapy With CDK 4/6 Inhibitors
By
PleXus Communications
FEATURING
Komal Jhaveri
By
PleXus Communications
FEATURING
Komal Jhaveri
This activity is supported by an educational grant from Lilly. For further information concerning Lilly ...
read more ↘
read more ↘
Login to view comments.
Click here to Login